BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24515802)

  • 1. Clarifying the impact of polycomb complex component disruption in human cancers.
    Yamamoto Y; Abe A; Emi N
    Mol Cancer Res; 2014 Apr; 12(4):479-84. PubMed ID: 24515802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KDM2B in polycomb repressive complex 1.1 functions as a tumor suppressor in the initiation of T-cell leukemogenesis.
    Isshiki Y; Nakajima-Takagi Y; Oshima M; Aoyama K; Rizk M; Kurosawa S; Saraya A; Kondo T; Sakaida E; Nakaseko C; Yokote K; Koseki H; Iwama A
    Blood Adv; 2019 Sep; 3(17):2537-2549. PubMed ID: 31471323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Age-Related Co-Expression of BCOR and BCORL1 mRNA in Acute Myeloid Leukemia.
    Coskun FR; Percin-Pacal F; Emrence Z; Ar MC; Abaci N; Unuvar A; Eskazan AE; Elverdi T; Salihoglu A; Seflekci Y; Karakas Z; Soysal T; Sirma-Ekmekci S
    Clin Lab; 2020 Aug; 66(8):. PubMed ID: 32776737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycomb group and SCF ubiquitin ligases are found in a novel BCOR complex that is recruited to BCL6 targets.
    Gearhart MD; Corcoran CM; Wamstad JA; Bardwell VJ
    Mol Cell Biol; 2006 Sep; 26(18):6880-9. PubMed ID: 16943429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCOR and BCORL1 mutations in myelodysplastic syndromes and related disorders.
    Damm F; Chesnais V; Nagata Y; Yoshida K; Scourzic L; Okuno Y; Itzykson R; Sanada M; Shiraishi Y; Gelsi-Boyer V; Renneville A; Miyano S; Mori H; Shih LY; Park S; Dreyfus F; Guerci-Bresler A; Solary E; Rose C; Cheze S; Prébet T; Vey N; Legentil M; Duffourd Y; de Botton S; Preudhomme C; Birnbaum D; Bernard OA; Ogawa S; Fontenay M; Kosmider O
    Blood; 2013 Oct; 122(18):3169-77. PubMed ID: 24047651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics analysis of Ring1B/Rnf2 interactors identifies a novel complex with the Fbxl10/Jhdm1B histone demethylase and the Bcl6 interacting corepressor.
    Sánchez C; Sánchez I; Demmers JA; Rodriguez P; Strouboulis J; Vidal M
    Mol Cell Proteomics; 2007 May; 6(5):820-34. PubMed ID: 17296600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of BCOR gene mutation as a prognostic factor in acute myeloid leukemia with intermediate cytogenetic prognosis.
    Terada K; Yamaguchi H; Ueki T; Usuki K; Kobayashi Y; Tajika K; Gomi S; Kurosawa S; Saito R; Furuta Y; Miyadera K; Tokura T; Marumo A; Omori I; Sakaguchi M; Fujiwara Y; Yui S; Ryotokuji T; Arai K; Kitano T; Wakita S; Fukuda T; Inokuchi K
    Genes Chromosomes Cancer; 2018 Aug; 57(8):401-408. PubMed ID: 29663558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BCOR and BCORL1 mutations in pediatric acute myeloid leukemia.
    de Rooij JD; van den Heuvel-Eibrink MM; Hermkens MC; Verboon LJ; Arentsen-Peters ST; Fornerod M; Baruchel A; Stary J; Reinhardt D; de Haas V; Pieters R; Zwaan CM
    Haematologica; 2015 May; 100(5):e194-5. PubMed ID: 25596268
    [No Abstract]   [Full Text] [Related]  

  • 9. Structure and Role of BCOR PUFD in Noncanonical PRC1 Assembly and Disease.
    Wong SJ; Senkovich O; Artigas JA; Gearhart MD; Ilangovan U; Graham DW; Abel KN; Yu T; Hinck AP; Bardwell VJ; Kim CA
    Biochemistry; 2020 Jul; 59(29):2718-2728. PubMed ID: 32628469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical Characteristics and Prognostic Significance of BCOR/BCORL1 Gene Mutation in Patients with Myelodysplastic Syndromes].
    Cen YX; Li Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):2004-2010. PubMed ID: 33283733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCOR Internal Tandem Duplication Expression in Neural Stem Cells Promotes Growth, Invasion, and Expression of PRC2 Targets.
    Nakata S; Yuan M; Rubens JA; Kahlert UD; Maciaczyk J; Raabe EH; Eberhart CG
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis.
    Oliviero G; Munawar N; Watson A; Streubel G; Manning G; Bardwell V; Bracken AP; Cagney G
    Sci Rep; 2015 Dec; 5():18388. PubMed ID: 26687479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mutations in BCOR in three patients with oculo-facio-cardio-dental syndrome, but none in Lenz microphthalmia syndrome.
    Horn D; Chyrek M; Kleier S; Lüttgen S; Bolz H; Hinkel GK; Korenke GC; Riess A; Schell-Apacik C; Tinschert S; Wieczorek D; Gillessen-Kaesbach G; Kutsche K
    Eur J Hum Genet; 2005 May; 13(5):563-9. PubMed ID: 15770227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oculofaciocardiodental and Lenz microphthalmia syndromes result from distinct classes of mutations in BCOR.
    Ng D; Thakker N; Corcoran CM; Donnai D; Perveen R; Schneider A; Hadley DW; Tifft C; Zhang L; Wilkie AO; van der Smagt JJ; Gorlin RJ; Burgess SM; Bardwell VJ; Black GC; Biesecker LG
    Nat Genet; 2004 Apr; 36(4):411-6. PubMed ID: 15004558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. KDM2B Recruitment of the Polycomb Group Complex, PRC1.1, Requires Cooperation between PCGF1 and BCORL1.
    Wong SJ; Gearhart MD; Taylor AB; Nanyes DR; Ha DJ; Robinson AK; Artigas JA; Lee OJ; Demeler B; Hart PJ; Bardwell VJ; Kim CA
    Structure; 2016 Oct; 24(10):1795-1801. PubMed ID: 27568929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene methylation in gastric cancer.
    Qu Y; Dang S; Hou P
    Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concurrent mutations in other epigenetic modulators portend better prognosis in BCOR-mutated myelodysplastic syndrome.
    Badaat I; Mirza S; Padron E; Sallman D; Komrokji R; Song J; Hussaini MO
    J Clin Pathol; 2020 Apr; 73(4):209-212. PubMed ID: 31771970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCOR gene alterations in hematologic diseases.
    Sportoletti P; Sorcini D; Falini B
    Blood; 2021 Dec; 138(24):2455-2468. PubMed ID: 33945606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BCOR involvement in cancer.
    Astolfi A; Fiore M; Melchionda F; Indio V; Bertuccio SN; Pession A
    Epigenomics; 2019 May; 11(7):835-855. PubMed ID: 31150281
    [No Abstract]   [Full Text] [Related]  

  • 20. Dynamics of epigenetic regulator gene BCOR mutation and response predictive value for hypomethylating agents in patients with myelodysplastic syndrome.
    Li X; Xu F; Zhang Z; Guo J; He Q; Song LX; Wu D; Zhou LY; Su JY; Xiao C; Chang CK; Wu LY
    Clin Epigenetics; 2021 Aug; 13(1):169. PubMed ID: 34461985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.